Some artificial intelligence (AI)-focused companies have delivered exceptional returns over the past few years, but some ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Vertex's CF drugs are bringing in billions of dollars in revenue, and in recent years the company has also expanded into ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

We're also trying to make sure we look back at some of the trades that are still alive so we can keep you posted. We wrote ...

Damian Garde joins Allison, Adam, and Elaine to discuss his article about Boris Nikolic, a well-connected biotech investor ...

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap ...

The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest ...

Biotech and drug-innovation themes continue to dominate markets—from AI-driven drug discovery to blockbuster obesity treatments—and a new ETF filing suggests asset managers want a piece of that ...

Investors are increasingly wary of the rare-disease space, spooked by a regulatory shift.

Tomorrow BioTech and The Super Crowd join forces to give biotech startups labs, crowdfunding, and capital to turn ...